Question 1

Is Estradiolo Emiidrato + Progesterone currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Estradiolo Emiidrato + Progesterone has 13 active shortage notices across 6 countries (United States, Colombia, Italy, Peru, Portugal, Belgium). Status is refreshed daily from official regulatory sources.

Question 2

Why is Estradiolo Emiidrato + Progesterone in shortage?

Accepted Answer

Regulators attribute the current Estradiolo Emiidrato + Progesterone shortages to supply-chain disruption, manufacturing problems, unexpected increases in demand. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Estradiolo Emiidrato + Progesterone shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 31 Dec 2021 to 31 Mar 2027, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Estradiolo Emiidrato + Progesterone shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
United States	high	4	29 May 2013	—	FDA MedWatch
Colombia	high	1	1 Jun 2026	—	INVIMA

Estradiolo Emiidrato + Progesterone shortage status

Where Estradiolo Emiidrato + Progesterone is in shortage

Why Estradiolo Emiidrato + Progesterone is in shortage

Recent shortage history

Frequently asked questions

Get alerted when Estradiolo Emiidrato + Progesterone status changes